Ascend Wellness (OTC:AAWH) Raised to “Hold” at Zacks Research

Ascend Wellness (OTC:AAWH) was upgraded by equities research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Wednesday,Zacks.com reports.

Ascend Wellness Price Performance

Ascend Wellness stock opened at $0.53 on Wednesday. Ascend Wellness has a 12-month low of $0.26 and a 12-month high of $1.20. The company has a current ratio of 1.47, a quick ratio of 0.80 and a debt-to-equity ratio of 2.61. The firm has a 50-day moving average price of $0.63 and a 200-day moving average price of $0.68. The firm has a market capitalization of $109.17 million, a PE ratio of -1.30 and a beta of 1.11.

Ascend Wellness Company Profile

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores.